BioNTech SE (BNTX) Change in Taxes (2018 - 2025)
BioNTech SE (BNTX) posted Change in Taxes of $90.3 million for Q4 2025, up 44.7% sequentially from $62.4 million in Q3 2025, and up 102.71% YoY from $44.6 million in Q4 2024.
BioNTech SE (BNTX) Change in Taxes (2018 - 2025) Analysis & Trends
BioNTech SE has reported Change in Taxes for 8 years, with the latest figure at $90.3 million in Q4 2025.
- Quarterly Change in Taxes rose 102.71% year-over-year to $90.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $103.4 million (up 803.48% YoY) and the FY2025 annual result came in at $96.4 million, up 827.31% from the prior year.
- Change in Taxes improved to $90.3 million in Q4 2025 per BNTX's latest filing, from $62.4 million in the prior quarter.
- Over five years, Change in Taxes peaked at $3.8 billion in Q3 2021 and troughed at -$241.5 million in Q2 2023.
- A 5-year average of $557.4 million and a median of $81.5 million in 2023 frame the typical range for Change in Taxes.
- The sharpest annual moves came in 2021 and 2025: Change in Taxes jumped 920631037.69% in 2021, then slumped 946.17% in 2025.
- Over 5 years, Change in Taxes stood at $1.8 billion in 2021, then sank by 48.49% to $912.0 million in 2022, then plunged by 75.78% to $220.9 million in 2023, then sank by 79.83% to $44.6 million in 2024, then jumped by 102.71% to $90.3 million in 2025.
- According to Business Quant data, Change in Taxes over the past three periods registered $90.3 million, $62.4 million, and -$18.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 90.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 90.33 Mn |
| Dec 31, 2025 | 90.33 Mn |
| Sep 30, 2025 | 62.43 Mn |
| Sep 30, 2025 | 62.43 Mn |
| Jun 30, 2025 | -18.22 Mn |
| Jun 30, 2025 | -18.22 Mn |
| Mar 31, 2025 | -31.14 Mn |
| Mar 31, 2025 | -31.14 Mn |
| Dec 31, 2024 | 44.56 Mn |
| Dec 31, 2024 | 44.56 Mn |
| Sep 30, 2024 | -43.27 Mn |
| Sep 30, 2024 | -43.27 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | -18.14 Mn |
| Mar 31, 2024 | -18.14 Mn |
| Dec 31, 2023 | 220.89 Mn |
| Dec 31, 2023 | 220.89 Mn |
| Sep 30, 2023 | 72.72 Mn |
| Sep 30, 2023 | 72.72 Mn |